Viewing StudyNCT00165191



Ignite Creation Date: 2024-05-05 @ 11:54 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00165191
Status: COMPLETED
Last Update Posted: 2009-04-28
First Post: 2005-09-09

Brief Title: Doxorubicin Cisplatin 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Organization Data

Organization: Dana-Farber Cancer Institute
Class: OTHER
Study ID: 98-048
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Dana-Farber Cancer Institute
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Massachusetts General Hospital OTHER
Brigham and Womens Hospital OTHER